26/07/2005 - Teva Pharmaceutical Industries continued its bid for world domination in the generic pharmaceuticals sector yesterday with a $7.4 billion cash and stock bid for US company Ivax, reports Phil Taylor.

Link to Article

In-PharmaTechnologist.com is the world's premier website for the latest breaking news on every aspect of pharmaceutical technology. This site is published by Novis, a business-to-business publisher that supplies strategically relevant news directly to the desktops of decision-makers in the pharmaceuticals, cosmetics and food industries.